Viewing Study NCT04545801



Ignite Creation Date: 2024-05-06 @ 3:10 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04545801
Status: COMPLETED
Last Update Posted: 2020-09-16
First Post: 2020-09-04

Brief Title: Ketamine for Analgesia After Cesarean Section
Sponsor: Mongi Slim Hospital
Organization: Mongi Slim Hospital

Study Overview

Official Title: Ketamine for Analgesia After Cesarean Section
Status: COMPLETED
Status Verified Date: 2020-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In this prospective randomized trial investigators compared the analgesic effect of subanesthetic dose of ketamine versus placebo in parturients undergoing cesarean section under spinal anesthesia
Detailed Description: In this prospective randomized trial investigators compared the analgesic effect of subanesthetic dose of ketamine versus placebo in parturients undergoing cesarean section under spinal anesthesia

The patients were randomized in two groups

Group Ketamine these patients recieved 025 mgkg of Ketamin intravenously 5 minutes after the spinal anesthesia
Group Placebo recieved 20 ml of normal saline solution intravenously 5 minutes after the spinal puncture

The investigators recorded intra demographic intraoperative and post operative data

The main outcome was the analgesic score the visual analog scale VAS dynamic VAS was also monitored at 24 hours post operatively

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None